Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-12 09:06 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
Controlled Trial on Effect of Montelukast Treatment in Children With Obstructive Sleep Apnea Syndrome
NCT00599534 · University of Louisville · PHASE2 · withdrawn · last registry update 2017-04-10 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
What was said, and by whom
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | “Principal Investigator has transferred to another Institution” | – | Registry record, University of Louisville |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against CYSLTR1 within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2018-03-13Results posted on the registry: University of Wisconsin, Madison, montelukast + placebo (NCT00359073)
- 2017-12-13Phase 3 first posted: Innovacion y Desarrollo de Estrategias en Salud, Montelukast mixed with Loratadine + Montelukast (NCT03372473)
- 2017-10-11Results posted on the registry: Indiana University, Efavirenz + Bupropion (NCT02401256)
- 2017-10-04Results posted on the registry: Stephanie Lee, fluticasone propionate + montelukast sodium (NCT01307462)
- 2017-09-06Results posted on the registry: GlaxoSmithKline, Fluticasone Propionate 100mcg via ACCUHALER/DISKUS + GSK2190915 100mg (NCT01147744)
- 2017-03-16Results posted on the registry: Milton S. Hershey Medical Center, daily fluticasone propionate + Montelukast (NCT01606306)
- 2017-03-08Results posted on the registry: GlaxoSmithKline, FF + Placebo (NCT02483975)
- 2017-02-06Results posted on the registry: University of Massachusetts, Worcester, Montelukast + Placebo (NCT00115297)
- 2017-02-03Results posted on the registry: GlaxoSmithKline, FP 100 + GSK2190915 100 (NCT01156792)
- 2016-10-21Results posted on the registry: National Cancer Institute (NCI), Singulair (Montelukast Sodium) (NCT00656058)
- 2016-10-12Results posted on the registry: University of California, San Diego, Fluticasone 250 mg/salmeterol 50 mg + Montelukast 10mg (NCT01696214)
- 2016-07-29Also stopped (terminated): National Heart, Lung, and Blood Institute (NHLBI), Budesonide + Salmeterol + Azithromycin + Budesonide + Salmeterol + Montelukast (NCT00471809)
- 2016-06-16Also stopped (withdrawn): Creighton University, Adding Advair Diskus 100/50mcg (FSC) BID and Singulair 10mg is added to placebo Diskus BID (NCT00385463)
- 2016-06-08Phase 3 first posted: Children's Hospital Medical Center, Cincinnati, Montelukast + Placebo (NCT02793375)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision